A threshold analysis assessed the credibility of conclusions from network meta-analysis

Objective To assess the reliability of treatment recommendations based on network meta-analysis (NMA). Study Design and Setting We consider evidence in an NMA to be potentially biased. Taking each pairwise contrast in turn, we use a structured series of threshold analyses to ask: (1) “How large would the bias in this evidence base have to be before it changed our decision?” and (2) “If the decision changed, what is the new recommendation?” We illustrate the method via two NMAs in which a Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessment for NMAs has been implemented: weight loss and osteoporosis. Results Four of the weight-loss NMA estimates were assessed as “low” and six as “moderate” quality by GRADE; for osteoporosis, six were “low,” nine were “moderate,” and 1 was “high.” The threshold analysis suggests plausible bias in 3 of 10 estimates in the weight-loss network could have changed the treatment recommendation. For osteoporosis, plausible bias in 6 of 16 estimates could change the recommendation. There was no relation between plausible bias changing a treatment recommendation and the original GRADE assessments. Conclusions Reliability judgments on individual NMA contrasts do not help decision makers understand whether a treatment recommendation is reliable. Threshold analysis reveals whether the final recommendation is robust against plausible degrees of bias in the data.

[1]  Anna Chaimani,et al.  Evaluating the Quality of Evidence from a Network Meta-Analysis , 2014, PloS one.

[2]  Douglas G. Altman,et al.  Models for potentially biased evidence in meta‐analysis using empirically based priors , 2009 .

[3]  Sander Greenland,et al.  Multiple‐bias modelling for analysis of observational data , 2005 .

[4]  H. Naci,et al.  No evidence of industry sponsorship bias in statin trials , 2014, BMJ : British Medical Journal.

[5]  Harald Binder,et al.  Visualizing the flow of evidence in network meta‐analysis and characterizing mixed treatment comparisons , 2013, Statistics in medicine.

[6]  Julian P T Higgins,et al.  Evidence-Based Prescribing: Combining Network Meta-Analysis With Multicriteria Decision Analysis to Choose Among Multiple Drugs , 2014, Circulation. Cardiovascular quality and outcomes.

[7]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[8]  H. Naci,et al.  Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins , 2014, BMJ : British Medical Journal.

[9]  Nicky J Welton,et al.  Evaluating novel agent effects in multiple‐treatments meta‐regression , 2010, Statistics in medicine.

[10]  Alex J. Sutton,et al.  Evidence Synthesis for Decision Making Inconsistency in Networks of Evidence Based on Randomized Controlled Trials. , 2013 .

[11]  Nicky J Welton,et al.  Study designs to detect sponsorship and other biases in systematic reviews. , 2010, Journal of clinical epidemiology.

[12]  Alexander J Sutton,et al.  What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. , 2004, Statistics in medicine.

[13]  Douglas G Altman,et al.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.

[14]  Elie A Akl,et al.  GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. , 2013, Journal of clinical epidemiology.

[15]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[16]  G. Lu,et al.  Combination of direct and indirect evidence in mixed treatment comparisons , 2004, Statistics in medicine.

[17]  Nicky J Welton,et al.  Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta‐analysis , 2010 .

[18]  G. Guyatt,et al.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.

[19]  Nicola J Cooper,et al.  Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications , 2009, BMJ : British Medical Journal.

[20]  M. Cowie National Institute for Health and Care Excellence. , 2015, European heart journal.

[21]  K Claxton,et al.  An economic approach to clinical trial design and research priority-setting. , 1996, Health economics.

[22]  A. Ades,et al.  Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

[23]  Ethan M Balk,et al.  Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials , 2012, Annals of Internal Medicine.

[24]  Nicky J Welton,et al.  Linear inference for mixed treatment comparison meta‐analysis: A two‐stage approach , 2011, Research synthesis methods.

[25]  Harald Binder,et al.  A graphical tool for locating inconsistency in network meta-analyses , 2013, BMC Medical Research Methodology.

[26]  Alex J. Sutton,et al.  Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment , 2011 .

[27]  Nicola J Cooper,et al.  Adjusting for publication biases across similar interventions performed well when compared with gold standard data. , 2011, Journal of clinical epidemiology.

[28]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[29]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[30]  Deborah M Caldwell,et al.  Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. , 2010, Journal of clinical epidemiology.

[31]  Alex J. Sutton,et al.  Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials. , 2013 .

[32]  David J Spiegelhalter,et al.  Bias modelling in evidence synthesis , 2009, Journal of the Royal Statistical Society. Series A,.

[33]  Georgia Salanti,et al.  Evaluation of networks of randomized trials , 2008, Statistical methods in medical research.

[34]  Deborah M Caldwell,et al.  NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials. , 2011 .

[35]  Kristian Thorlund,et al.  Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. , 2014, JAMA.

[36]  Mohammad Hassan Murad,et al.  A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis , 2014, BMJ : British Medical Journal.

[37]  Simon G. Thompson,et al.  Meta‐Analysis of Clinical Trials , 2005 .

[38]  Ross J. Harris,et al.  Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. , 2012, Health technology assessment.